Investigational Drug Information for Cadazolid
✉ Email this page to a colleague
What is the development status for investigational drug Cadazolid?
Cadazolid is an investigational drug.
There have been 5 clinical trials for Cadazolid.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 27th 2014.
The most common disease conditions in clinical trials are Clostridium Infections, Diarrhea, and Infection. The leading clinical trial sponsors are Actelion and [disabled in preview].
There are ten US patents protecting this investigational drug and one hundred and fifty-five international patents.
Summary for Cadazolid
US Patents | 10 |
International Patents | 155 |
US Patent Applications | 42 |
WIPO Patent Applications | 23 |
Japanese Patent Applications | 8 |
Clinical Trial Progress | Phase 3 (2014-03-27) |
Vendors | 31 |
Recent Clinical Trials for Cadazolid
Title | Sponsor | Phase |
---|---|---|
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) | Actelion | Phase 2/Phase 3 |
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea | Actelion | Phase 3 |
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | Actelion | Phase 3 |
Clinical Trial Summary for Cadazolid
Top disease conditions for Cadazolid
Top clinical trial sponsors for Cadazolid
US Patents for Cadazolid
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Cadazolid | ⤷ Try a Trial | Crystalline forms of cadazolid | ⤷ Try a Trial | |
Cadazolid | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
Cadazolid | ⤷ Try a Trial | Clostridium difficile toxin inhibitors | Venenum Biodesign, LLC (Hamilton, NJ) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Cadazolid
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Cadazolid | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
Cadazolid | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
Cadazolid | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |